National Academies Press: OpenBook

Preparing for Future Products of Biotechnology (2017)

Chapter: Appendix C: Requests for Information

« Previous: Appendix B: Agendas of Information-Gathering Sessions
Suggested Citation:"Appendix C: Requests for Information." National Academies of Sciences, Engineering, and Medicine. 2017. Preparing for Future Products of Biotechnology. Washington, DC: The National Academies Press. doi: 10.17226/24605.
×

Appendix C

Requests for Information

In an attempt to better ascertain the nature and extent of federal research designed to support risk analyses of biotechnology products, the committee solicited input from relevant agencies through a request for information (RFI). The questions posed through the RFI were derived, in part, from the report Creating a Research Agenda for Ecological Implications of Synthetic Biology published in 2014 following two workshops organized by the Massachusetts Institute of Technology Program on Emerging Technologies and the Wilson Center’s Synthetic Biology Project (Drinkwater et al., 2014) and a workshop and Delphi study on synthetic-biology governance (Roberts et al., 2015). The committee was interested in programmatic work related to fundamental and applied research efforts that can inform human, animal, and ecological risk assessments and social and economic costs and benefits. Research related to potential risks of future human drugs or medical devices was not included in the committee’s statement of task and therefore was not part of this RFI, except to the extent such research may be broadly applicable to other biotechnology products.

REQUEST SENT TO AGENCIES

“Rapid scientific advances are expanding the types of products that can be generated through biotechnology. In response to a request from the White House Office of Science and Technology Policy, the National Academies of Sciences, Engineering, and Medicine have convened a committee of experts to identify the kinds of products that may be produced with biotechnology in the next 10 years. The U.S. regulatory system for biotechnology products was originally designed in the 1980s, so the committee will also provide advice on the scientific capabilities, tools, and expertise that may be necessary to regulate those forthcoming products and on whether potential future products could pose different types of risks relative to existing products and organisms. The committee’s report is expected to be released at the end of 2016.

“To help it address its statement of task, the Academies committee is requesting information on the status of federal research programs that address future biotechnology products. The questions below are derived, in part, from the report Creating a Research Agenda for Ecological Implications of Synthetic Biology, published in 2014 following two workshops organized by the Massachusetts

Suggested Citation:"Appendix C: Requests for Information." National Academies of Sciences, Engineering, and Medicine. 2017. Preparing for Future Products of Biotechnology. Washington, DC: The National Academies Press. doi: 10.17226/24605.
×

Institute of Technology Program on Emerging Technologies and the Wilson Center’s Synthetic Biology Project. The committee is interested in programmatic work related to fundamental and applied research efforts that can inform human, animal, and ecological risk assessments and socioeconomic costs and benefits. Research related to potential risks of future human drugs or medical devices is not included in the committee’s statement of task and is therefore not part of this request for information (RFI), except to the extent such research may be broadly applicable to other biotechnology products.

“This RFI addresses the level of intramural and extramural research investments for fiscal years 2012, 2013, 2014, 2015, and 2016 (current and anticipated obligations). It also includes a general question concerning research planning and processes whereby research products are adapted and vetted for use in future risk analyses.”

Requested Information

“Please provide an estimate of intramural Full-Time Employees and extramural obligations by fiscal year (FY2012, FY2013, FY2014, FY2015, and FY2016) in each of the areas outlined below. As available, please provide links to associated project descriptions and links to any peer-reviewed publications.

  1. Comparators. Research addressing the nature and extent to which comparisons of future modified organisms, or communities of modified organisms (including those associated with the human microbiome), can be made to wild-type organisms or communities of organisms, to inform problem formulation, risk characterization, and post-market monitoring and surveillance. Include research to address scenarios where there are no “present-day” analogues to the modified organisms.
  2. Nontarget Gene Effects and Phenotypic Characterization. Research addressing techniques to assess the nature and extent of effects on nontarget genes and unintended phenotypes; understanding phenotypic functions of new traits and how the environment influences expression of the functions; phenotypic characteristics most relevant to near-term perturbations versus long-term consequences in humans, other organisms, communities, or ecosystems.
  3. Impacts on Nontarget Organisms. Research addressing exposure of future biotechnology products to humans and other nontarget organisms and resultant toxicity (including allergenic responses). Research addressing changes in nontarget species’ populations through indirect effects of future biotechnology products due to perturbations in trophic relationships (e.g., reductions in prey and other food sources) and habitat alteration.
  4. Fitness, Genetic Stability, and Lateral Gene Transfer. Research addressing approaches to assess gene persistence and stability of genetic material across generations; potential for genes to transfer to unrelated species with increased consistency and reliability.
  5. Control of Organismal Traits. Research addressing intrinsic and external control measures designed to meet specified levels of risk mitigation for intentional or accidental releases.
  6. Life-Cycle Analyses. Research on the effects future biotechnology products may have on life-cycle processes, such as water utilization and fossil fuel and mineral extraction and consumption.
  7. Monitoring and Surveillance. Research addressing options for indicators and spatial and temporal sampling designs for human subpopulations, animals, and ecosystems for broad-based detection capabilities or specific applications in proactive or reactive situations.
Suggested Citation:"Appendix C: Requests for Information." National Academies of Sciences, Engineering, and Medicine. 2017. Preparing for Future Products of Biotechnology. Washington, DC: The National Academies Press. doi: 10.17226/24605.
×
  1. Modeling. Research on the use of conceptual models (e.g., in the problem formulation step of risk assessments), physical models (e.g., human organs on a chip, mesocoms), and computational models to help inform risk-based hypotheses in assessments, to direct collection of additional data to reduce uncertainties in assessments, or to provide definitive findings or predictions in risk characterization.
  2. Economic Costs and Benefits. Research on techniques to quantify the near-term and long-term economic costs and benefits of future products, including comparative analyses with extant products, that address household, community, regional, national, and international scales.
  3. Social Costs and Benefits. Research on techniques to quantify the near-term and long-term social costs and benefits of future products, including comparative analyses with extant products, that address household, community, regional, national, and international scales.
  4. Other Areas of Research not addressed above.
  5. Please describe research planning processes within your organization and with sister federal agencies. To what extent do risk assessors, risk managers, grant project officers, intramural researchers, and, as appropriate, extramural researchers, meet on a regular basis to identify future research needs and identify steps by which anticipated research products will be adapted and vetted for use in risk assessments or socioeconomic cost–benefit analyses? For example, are there ongoing discussions concerning the nature and extent of potential monitoring and/or surveillance needs for the future? Are there ongoing discussions concerning approaches for standardizing methods for data collection and management?”

RESPONSES FROM AGENCIES

Agency Name Responded with Information Responded But No Material to Submit No Response
Air Force Office of Scientific Research
U.S. Air Force
X
Air Force Research Laboratory X
Army Research Laboratory X
Army Research Laboratory
Institute for Collaborative Biotechnologies
X
Defense Advanced Research Projects Agency X
Defense Threat Reduction Agency X
Intelligence Advanced Research Projects Activity X
National Institute of Standards and Technology X
National Oceanic and Atmosphere Administration
Northwest Fisheries Science Center
X
Suggested Citation:"Appendix C: Requests for Information." National Academies of Sciences, Engineering, and Medicine. 2017. Preparing for Future Products of Biotechnology. Washington, DC: The National Academies Press. doi: 10.17226/24605.
×
Agency Name Responded with Information Responded But No Material to Submit No Response
National Oceanic and Atmosphere Administration
Southwest Fisheries Science Center
X
National Science Foundation
Chemical, Bioengineering, Environmental, & Transport Systems
X
National Science Foundation
Division of Environmental Biology
X
National Science Foundation
Division of Industrial Innovation & Partnerships
X
National Science Foundation
Division of Molecular & Cellular Biosciences
X
National Science Foundation
Division of Social and Economic Sciences
X
National Science Foundation
Office of Emerging Frontiers
X
National Science Foundation
Office of Emerging Frontiers in Research & Innovation
X
Office of Naval Research X
U.S. Army Corps of Engineers X
U.S. Department of Agriculture X
U.S. Department of Energy
Office of Biological and Environmental Research
X
U.S. Department of Energy
Office of Energy Efficiency & Renewable Energy
X
U.S. Department of the Interior
National Invasive Species Council
X
U.S. Environmental Protection Agency
Office of Pesticide Programs
X
U.S. Environmental Protection Agency
Office of Pollution Prevention and Toxics
X
U.S. Fish and Wildlife Service X
U.S. Food and Drug Administration X
U.S. Geological Survey X
Suggested Citation:"Appendix C: Requests for Information." National Academies of Sciences, Engineering, and Medicine. 2017. Preparing for Future Products of Biotechnology. Washington, DC: The National Academies Press. doi: 10.17226/24605.
×

REFERENCES

Drinkwater, K., T. Kuiken, S. Lightfoot, J. McNamara, and K. Oye. 2014. Creating a Research Agenda for the Ecological Implications of Synthetic Biology. Joint Workshops by the MIT Program on Emerging Technologies and the Wilson Center’s Synthetic Biology Project. Available at https://www.wilsoncenter.org/sites/default/files/SYNBIO_create%20an%20agenda_v4.pdf. Accessed August 10, 2016.

Roberts, J.P., S. Stauffer, C. Cummings, and J. Kuzma. 2015. Synthetic Biology Governance: Delphi Study Workshop Report. GES Center Report No. 2015.2. Available at https://research.ncsu.edu/ges/files/2014/04/Sloan-Workshop-Report-final-ss-081315-1.pdf. Accessed October 10, 2016.

Suggested Citation:"Appendix C: Requests for Information." National Academies of Sciences, Engineering, and Medicine. 2017. Preparing for Future Products of Biotechnology. Washington, DC: The National Academies Press. doi: 10.17226/24605.
×

This page intentionally left blank.

Suggested Citation:"Appendix C: Requests for Information." National Academies of Sciences, Engineering, and Medicine. 2017. Preparing for Future Products of Biotechnology. Washington, DC: The National Academies Press. doi: 10.17226/24605.
×
Page 203
Suggested Citation:"Appendix C: Requests for Information." National Academies of Sciences, Engineering, and Medicine. 2017. Preparing for Future Products of Biotechnology. Washington, DC: The National Academies Press. doi: 10.17226/24605.
×
Page 204
Suggested Citation:"Appendix C: Requests for Information." National Academies of Sciences, Engineering, and Medicine. 2017. Preparing for Future Products of Biotechnology. Washington, DC: The National Academies Press. doi: 10.17226/24605.
×
Page 205
Suggested Citation:"Appendix C: Requests for Information." National Academies of Sciences, Engineering, and Medicine. 2017. Preparing for Future Products of Biotechnology. Washington, DC: The National Academies Press. doi: 10.17226/24605.
×
Page 206
Suggested Citation:"Appendix C: Requests for Information." National Academies of Sciences, Engineering, and Medicine. 2017. Preparing for Future Products of Biotechnology. Washington, DC: The National Academies Press. doi: 10.17226/24605.
×
Page 207
Suggested Citation:"Appendix C: Requests for Information." National Academies of Sciences, Engineering, and Medicine. 2017. Preparing for Future Products of Biotechnology. Washington, DC: The National Academies Press. doi: 10.17226/24605.
×
Page 208
Next: Appendix D: Congressionally Defined Product Categories That the U.S. Food and Drug Administration Regulates »
Preparing for Future Products of Biotechnology Get This Book
×
Buy Paperback | $74.00 Buy Ebook | $59.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Between 1973 and 2016, the ways to manipulate DNA to endow new characteristics in an organism (that is, biotechnology) have advanced, enabling the development of products that were not previously possible. What will the likely future products of biotechnology be over the next 5–10 years? What scientific capabilities, tools, and/or expertise may be needed by the regulatory agencies to ensure they make efficient and sound evaluations of the likely future products of biotechnology?

Preparing for Future Products of Biotechnology analyzes the future landscape of biotechnology products and seeks to inform forthcoming policy making. This report identifies potential new risks and frameworks for risk assessment and areas in which the risks or lack of risks relating to the products of biotechnology are well understood.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!